Healthcare shares are flat to lower in pre-market trade.
In healthcare stocks news, Dendreon Corp (
) rose nearly 18% in pre-market trading after a Bloomberg report
said the company is seeking a buyer and have hired JPMorgan Chase
& Co to help with the search.
Citing unnamed people with knowledge of the situation, Bloomberg
said the strategic shift resulted after the company's prostate
cancer treatment drug sales failed to meet expectations.
In contrast, Synta Pharmaceuticals (
) is down 19.2% this morning after it announced presentation of
results from the GALAXY-1 trial, a global, randomized, multi-center
study designed to identify the patients with advanced non-small
cell lung adenocarcinoma most likely to benefit from second-line
treatment with the company's lead drug candidate, the Hsp90
inhibitor ganetespib, in combination with docetaxel versus
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.